GABAergic and dopaminergic systems of the substantia nigra and amygdaloid kindling in cats.
D000614:Aminocaproates / Q000627:therapeutic use; D000679:Amygdala / Q000502:physiology*; D000818:Animals; D002415:Cats; D004056:Differential Threshold; D004298:Dopamine / Q000502:physiology*; D006892:Hydroxydopamines / Q000494:pharmacology; D007267:Injections; D007696:Kindling, Neurologic; D016627:Oxidopamine; D012640:Seizures / Q000188:drug therapy / Q000503:physiopathology; D013378:Substantia Nigra / Q000502:physiology*; D013997:Time Factors; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D000614:Aminocaproates; D006892:Hydroxydopamines; D005680:gamma-Aminobutyric Acid; D016627:Oxidopamine; D020888:Vigabatrin; D004298:Dopamine